<DOC>
	<DOCNO>NCT01174979</DOCNO>
	<brief_summary>This trial randomize , double blind , placebo control study patient suffer inner ear disease tinnitus principal symptom . The study investigate transtympanic treatment 1,5 % caroverine solution . Each patient undergo treatment 2 cycle 48 hour .</brief_summary>
	<brief_title>Caroverin Inner Ear Diseases</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Men woman age least eighteen Written consent take part study receive information trial physician One follow illness : Decompensated tinnitus Sudden hearing loss Morbus Menière Blast injury Presbyacusis Tinnitus Chron . Otitis medium Patients able give consent ( e.g . dementia , coma , mental disability , … ) Women childbearing age use adequate contraception ( plan become ) pregnant ( pregnancy test must carry doctor month Austria ) lactate If solid reason doubt patient would willing able cooperate Known intolerance of/hypersensitivity caroverine Subjects take part another clinical trial within 30 day precede start study study Pulsesynchronous tinnitus Tinnitus cause malposition jaw bone ( bruxism ) Eardrum perforation Subjects previously barotraumas , dive accident decompression sickness Retrocochlear hearing disorder Patients previously fracture petrous bone Subjects suffer acute chronic accompany condition severely impede general health ( NYHA stage IV , cancer , HIV etc . ) Accompanying condition accord current state scientific knowledge could affect parameter use study extent make impossible perform objective assessment parameter , particularly ear condition , include condition affect ear condition like HI NYHA stage IV , cancer , HIV , Wallenberg Syndrome , massive Hypotension , Glaucoma . ) Accompanying medication accord current state scientific knowledge likely affect measurement technique use study result obtain ( cytostatics , aminoglycoside antibiotic , loop diuretic ( furosemide , etacrynic acid ) , psycho pharmaceutical , muscle relaxant , benzodiazepine , salicylate , quinine , cortisone and/or caroverine within three day precede start study ) Drug treatment tinnitus sudden hearing loss ( i.v . oral ) within seven day precede start study total duration course le four week Diseases condition may associate altered perception processing stimulus , e.g . mental illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Morbus Meniere</keyword>
	<keyword>Sudden hearing loss</keyword>
	<keyword>Blast injury</keyword>
	<keyword>Presbyacusis</keyword>
	<keyword>Chron . Otitis Media</keyword>
</DOC>